Drug Clinical Trials:
News on drug clinical trials, articles on tests or new drugs and medication.
-
Mar 3rd, 2005
A new and experimental breast cancer drug called lapatinib inhibited tumor growth in nearly half of women who took it for eight weeks in a national Phase I clinical trial.
-
Mar 3rd, 2005
Findings could ultimately lead to improved drugs to prevent or treat Salmonella infections.
-
Mar 3rd, 2005
Immunologists have pinpointed how a widely used treatment for non Hodgkin's lymphoma attacks abnormal immune cells, called B cells.
-
Mar 3rd, 2005
For the first time, biochemists have used computational design methods to transform a protein devoid of catalytic activity into a biologically active enzyme.
-
Mar 2nd, 2005
The convenience of a newer formulation of the blood thinner heparin, called enoxaparin, appear to make it the drug of choice for treating patients with suspected heart attacks. Heparin reduces clotting by blocking the action of thrombin.
-
Mar 2nd, 2005
Leukemia patients who take the anti cancer drug imatinib mesylate (brand-name Gleevec) are at increased risk for developing suppressed immune systems.
-
Mar 1st, 2005
Development of drugs to treat a broad array of diseases, including cancer, hypertension, diabetes, inflammation and infectious diseases, could become enormously more effective through the process of "proteome mining."
